Replies to post #501122 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

fabricated b.s. only made it halfway through 3rd sentence

[Dr Bala]

Totally false. The trial results prove that DCVax-L is efficacious against rGBM too.

[sentiment_stocks]

So exactly how does this, what you call so-called “second dose”, affect the patient’s overall survival?

What that does is gives the patient a second dose that very likely affects their overall survival (OS).

LOLs

[CherryTree1]

OK so you are saying DCVAX-L is clearly an effective treatment and for those that received an additional dose even more effective. What is the delay lets Fast Track Approval and get this to the patients that need it.

. . . that does is gives the patient a second dose that very likely affects their overall survival (OS). NWBO has repeated stated that that crossover dosing confound the OS data -- that creates significant bias in the trial in the favor of DCVax-L as they get more doses that the SoC control arm . . .

[CrashOverride]

The fact that DCVax worked so well for crossover group, or rGBM, means it's the one stop shop for killing Glioblastoma. Thank you for making the case for approval!